Modification of the relationship between blood pressure and renal albumin permeability by impaired excretory function and diabetes

Hypertension

Volumn 65, Issue 3, 2015, Pages 510-516

  Fotheringham, James ^a   Odudu, Aghogho ^b   Mckane, William ^a   Ellam, Timothy ^a,c  

^a NORTHERN GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

albuminuria; autoregulation; blood pressure; diabetes mellitus; eGFR

Indexed keywords

ALBUMIN; CREATININE; ALBUMINOID;

ADULT; ALBUMINURIA; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BRACHIAL ARTERY; CREATININE URINE LEVEL; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; EXCRETION; FEMALE; GLOMERULUS; GLOMERULUS FILTRATION; GLOMERULUS FILTRATION RATE; HUMAN; HYDROSTATIC PRESSURE; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; NEPHRON; PRIORITY JOURNAL; RENAL SYSTEM PARAMETERS; SYSTOLIC BLOOD PRESSURE; URINE LEVEL; AGED; BIOLOGICAL MODEL; CELL MEMBRANE PERMEABILITY; HYPERTENSION; KIDNEY DISEASE; METABOLISM; MIDDLE AGED; NUTRITION; PATHOPHYSIOLOGY; PHYSIOLOGY; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; UNITED STATES;

ADULT; AGED; ALBUMINS; ALBUMINURIA; BLOOD PRESSURE; CELL MEMBRANE PERMEABILITY; DIABETES MELLITUS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; KIDNEY DISEASES; KIDNEY GLOMERULUS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; NUTRITION SURVEYS; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 84924281133     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.114.04656     Document Type: Article

References (29)

1. Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group. KDIGO 2012 clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int Supplements. 2012;2:337-414.
2. Sarafidis PA, Ruilope LM. Aggressive blood pressure reduction and reninangiotensin system blockade in chronic kidney disease: time for re-evaluation? Kidney Int. 2014;85:536-546. doi: 10.1038/ki.2013.355.
3. Anderson S, Meyer TW, Rennke HG, Brenner BM. Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest. 1985;76:612-619. doi: 10.1172/JCI112013.
4. Brown SA, Finco DR, Crowell WA, Choat DC, Navar LG. Single-nephron adaptations to partial renal ablation in the dog. Am J Physiol. 1990;258(3 Pt 2):F495-F503.
5. Olson JL, Hostetter TH, Rennke HG, Brenner BM, Venkatachalam MA. Altered glomerular permselectivity and progressive sclerosis following extreme ablation of renal mass. Kidney Int. 1982;22:112-126.
6. Bidani AK, Griffin KA. Pathophysiology of hypertensive renal damage: implications for therapy. Hypertension. 2004;44:595-601. doi: 10.1161/01.HYP.0000145180.38707.84.
7. Peterson JC, Adler S, Burkart JM, Greene T, Hebert LA, Hunsicker LG, King AJ, Klahr S, Massry SG, Seifter JL. Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann Intern Med. 1995;123:754-762.
8. Appel LJ, Wright JT Jr, Greene T, et al.; AASK Collaborative Research Group. Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med. 2010;363:918-929. doi: 10.1056/NEJMoa0910975.
9. Bidani AK, Griffin KA. Chronic kidney disease: blood-pressure targets in chronic kidney disease. Nat Rev Nephrol. 2011;7:128-130. doi: 10.1038/nrneph.2010.168.
10. Lv J, Ehteshami P, Sarnak MJ, Tighiouart H, Jun M, Ninomiya T, Foote C, Rodgers A, Zhang H, Wang H, Strippoli GF, Perkovic V. Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis. CMAJ. 2013;185:949-957. doi: 10.1503/cmaj.121468.
11. Ellam TJ, El Nahas M. Proteinuria thresholds are irrational: a call for proteinuria indexing. Nephron Clin Pract. 2011;118:c217-c224. doi: 10.1159/000321687.
12. Carmines PK. The renal vascular response to diabetes. Curr Opin Nephrol Hypertens. 2010;19:85-90. doi: 10.1097/MNH.0b013e32833240fc.
13. Centers for Disease Control and Prevention. National health and nutrition examinations survey. http://www.Cdc.Gov/nchs/nhanes.Htm Accessed August 1, 2014.
14. Centers for Disease Control and Prevention. NHANES physician examination procedures manual. http://www.Cdc.Gov/nchs/data/nhanes/nhanes-05-06/pe.Pdf Accessed August 1, 2014.
15. Selvin E, Manzi J, Stevens LA, Van Lente F, Lacher DA, Levey AS, Coresh J. Calibration of serum creatinine in the national health and nutrition examination surveys (NHANES) 1988-1994, 1999-2004. Am J Kidney Dis. 2007;50:918-926.
16. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604-612.
17. Johnson CL, Paulose-Ram R, Ogden CL, Carroll MD, Kruszon-Moran D, Dohrmann SM, Curtin LR. National health and nutrition examination survey: Analytic guidelines 1999-2010. Vital Health Stat. 2013;164:1-24.
18. Bidani AK, Hacioglu R, Abu-Amarah I, Williamson GA, Loutzenhiser R, Griffin KA. "Step" vs. "dynamic" autoregulation: implications for susceptibility to hypertensive injury. Am J Physiol Renal Physiol. 2003;285:F113-F120. doi: 10.1152/ajprenal.00012.2003.
19. Saxena AB, Myers BD, Derby G, Blouch KL, Yan J, Ho B, Tan JC. Adaptive hyperfiltration in the aging kidney after contralateral nephrectomy. Am J Physiol Renal Physiol. 2006;291:F629-F634. doi: 10.1152/ajprenal.00329.2005.
20. Ibrahim HN, Foley R, Tan L, Rogers T, Bailey RF, Guo H, Gross CR, Matas AJ. Long-term consequences of kidney donation. N Engl J Med. 2009;360:459-469. doi: 10.1056/NEJMoa0804883.
21. O'Rourke MF, Safar ME. Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. Hypertension. 2005;46:200-204. doi: 10.1161/01.HYP.0000168052.00426.65.
22. Weir MR, Townsend RR, Fink JC, et al. Hemodynamic correlates of proteinuria in chronic kidney disease. Clin J Am Soc Nephrol. 2011;6:2403-2410. doi: 10.2215/CJN.01670211.
23. Loutzenhiser R, Griffin K, Williamson G, Bidani A. Renal autoregulation: new perspectives regarding the protective and regulatory roles of the underlying mechanisms. Am J Physiol Regul Integr Comp Physiol. 2006;290:R1153-R1167. doi: 10.1152/ajpregu.00402.2005.
24. Kalaitzidis RG, Bakris GL. Prehypertension: is it relevant for nephrologists? Kidney Int. 2010;77:194-200. doi: 10.1038/ki.2009.439.
25. Kario K, Kanai N, Nishiuma S, Fujii T, Saito K, Matsuo T, Matsuo M, Shimada K. Hypertensive nephropathy and the gene for angiotensin-converting enzyme. Arterioscler Thromb Vasc Biol. 1997;17:252-256.
26. Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med. 2004;164:659-663. doi: 10.1001/archinte.164.6.659.
27. Verhave JC, Hillege HL, Burgerhof JG, Navis G, de Zeeuw D, de Jong PE; PREVEND Study Group. Cardiovascular risk factors are differently associated with urinary albumin excretion in men and women. J Am Soc Nephrol. 2003;14:1330-1335.
28. Russo LM, Sandoval RM, McKee M, Osicka TM, Collins AB, Brown D, Molitoris BA, Comper WD. The normal kidney filters nephrotic levels of albumin retrieved by proximal tubule cells: retrieval is disrupted in nephrotic states. Kidney Int. 2007;71:504-513. doi: 10.1038/sj.ki.5002041.
29. Peti-Peterdi J. Independent two-photon measurements of albumin GSC give low values. Am J Physiol Renal Physiol. 2009;296:F1255-F1257. doi: 10.1152/ajprenal.00144.2009.